Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Has announcements × CNS × Clear all

Phase

Status

Sponsor Class

INDUSTRY 20 OTHER 2 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 3 Other hematologic neoplasm 3 Lymphoid 2 Thoracic 1 Other solid neoplasm 1 Myeloid 1 CNS 1

Conditions

Neuroblastoma 1 Lymphoma, Large-Cell, Anaplastic 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00939770 2020-06-09

Crizotinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma

Children's Oncology Group

Phase 1/2 Completed

122 enrolled 24 charts 2 FDA

Neuroblastoma, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡